1. Home
  2. Browse
  3. Bone & Joint
  4. Osteoporosis
  5. Treatment

Treatment

31 - 45 of 62 Results
Sort Results:
PL Voices: Choosing a Treatment for Osteoporosis July 2012
Commentary: Delayed-release Risedronate (Actonel DR) November 2011
Commentary: Safety of Long-Term Bisphosphonate Therapy November 2011
PL Voices: Bisphosphonates for Osteoporosis November 2011
Article: more controversy about how long patients should take bisphosphonates (alendronate, etc) for osteoporosis November 2011
Article: Actonel DR, a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis November 2011
Other: FDA Podcast: Bisphosphonates and Risk of Esophageal Cancer (July 2011) October 2010
Commentary: Bisphosphonates: Esophageal Cancer and Other Safety Concerns October 2010
Article: new concerns that bisphosphonates might increase the risk of esophageal cancer and femur fractures October 2010
Article: new injectable monoclonal antibody for osteoporosis called Prolia (PRO-lee-a, denosumab) September 2010
Article: oral bisphosphonates (Fosamax, etc) might decrease the risk of breast cancer January 2010
Article: how long women should take a bisphosphonate for osteoporosis December 2009
Guideline: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Prevention and Treatment Of Postmenopausal Osteoporosis: 2001 Edition, with Selected Updates for 2003 December 2009
Guideline: Menopause and Osteoporosis Update (Canadian) (2009) December 2009
Guideline: Prevention and Treatment of Osteoporosis (NOF) (2013) December 2009